Gilder Gagnon Howe & Co’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-27,832
| Closed | -$219K | – | 324 |
|
2020
Q1 | $219K | Sell |
27,832
-401,269
| -94% | -$3.16M | ﹤0.01% | 239 |
|
2019
Q4 | $8.88M | Sell |
429,101
-70,964
| -14% | -$1.47M | 0.09% | 140 |
|
2019
Q3 | $6.85M | Sell |
500,065
-340,585
| -41% | -$4.67M | 0.08% | 145 |
|
2019
Q2 | $10.3M | Sell |
840,650
-521,736
| -38% | -$6.42M | 0.1% | 126 |
|
2019
Q1 | $17M | Sell |
1,362,386
-1,027,574
| -43% | -$12.8M | 0.18% | 105 |
|
2018
Q4 | $27.1M | Sell |
2,389,960
-271,940
| -10% | -$3.08M | 0.38% | 66 |
|
2018
Q3 | $49.8M | Sell |
2,661,900
-788,647
| -23% | -$14.8M | 0.51% | 61 |
|
2018
Q2 | $89.2M | Sell |
3,450,547
-248,695
| -7% | -$6.43M | 0.96% | 31 |
|
2018
Q1 | $82.9M | Sell |
3,699,242
-50,330
| -1% | -$1.13M | 1.03% | 26 |
|
2017
Q4 | $93.9M | Sell |
3,749,572
-212,075
| -5% | -$5.31M | 1.26% | 18 |
|
2017
Q3 | $95.8M | Sell |
3,961,647
-305,517
| -7% | -$7.39M | 1.35% | 18 |
|
2017
Q2 | $86.3M | Sell |
4,267,164
-17,248
| -0.4% | -$349K | 1.28% | 18 |
|
2017
Q1 | $115M | Sell |
4,284,412
-94,590
| -2% | -$2.55M | 1.94% | 8 |
|
2016
Q4 | $83.3M | Buy |
4,379,002
+392,904
| +10% | +$7.47M | 1.64% | 9 |
|
2016
Q3 | $77.9M | Sell |
3,986,098
-321,772
| -7% | -$6.29M | 1.34% | 17 |
|
2016
Q2 | $64.5M | Buy |
4,307,870
+927,625
| +27% | +$13.9M | 1.28% | 20 |
|
2016
Q1 | $31.1M | Buy |
3,380,245
+1,313,244
| +64% | +$12.1M | 0.61% | 46 |
|
2015
Q4 | $39.8M | Sell |
2,067,001
-205,008
| -9% | -$3.95M | 0.64% | 40 |
|
2015
Q3 | $33.8M | Sell |
2,272,009
-25,141
| -1% | -$374K | 0.54% | 51 |
|
2015
Q2 | $50.3M | Buy |
2,297,150
+4,683
| +0.2% | +$103K | 0.66% | 44 |
|
2015
Q1 | $51.6M | Buy |
2,292,467
+718,619
| +46% | +$16.2M | 0.72% | 44 |
|
2014
Q4 | $31.8M | Buy |
+1,573,848
| New | +$31.8M | 0.47% | 55 |
|